Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Sarcoma 2Multiple Myeloma 2Lung Neoplasms 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fatigue 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Splenomegaly 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pain 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Surveys and Questionnaires 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2Ritonavir 1Quality of Life 1ON 01910 1Nivolumab 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Splenomegaly × Quality of Life × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡